Key result
Cirrhotic cardiomyopathy and hepatopulmonary syndrome share clinical presentations like dyspnea but require early differentiation due to distinct pathophysiological mechanisms and treatments.
Why the study?
Cirrhotic cardiomyopathy and hepatopulmonary syndrome share a common pathophysiological origin and presentation with dyspnea, making early differentiation critical given their different treatments prior to liver transplant.
Cirrhotic cardiomyopathy and hepatopulmonary syndrome share clinical presentations like dyspnea but require early differentiation due to distinct pathophysiological mechanisms and treatments prior to liver transplant.
Differentiation of cirrhotic cardiomyopathy from hepatopulmonary syndrome may guide pre-transplant care; leaves open standardized diagnostic protocols in cirrhosis.
Cirrhotic cardiomyopathy and hepatopulmonary syndrome are two quite frequent clinical entities that may complicate the course of liver cirrhosis. The common pathophysiological origin and the same clinical presentation make them difficult to compare. Cirrhotic cardiomyopathy and hepatopulmonary syndrome may start with dyspnea and breathlessness but the former is characterized by a chronic cardiac dysfunction and the latter by a defect of oxygenation due to pulmonary shunts formation. The focus is to differentiate them as soon as possible since the treatment is different until the patient undergoes liver transplant that is the real unique cure for them.
No takes yet. Share an insight, caveat, or question.
Zardi et al. (2020) conducted a review in Liver cirrhosis complications (cirrhotic cardiomyopathy and hepatopulmonary syndrome). Cirrhotic cardiomyopathy and hepatopulmonary syndrome share clinical presentations like dyspnea but require early differentiation due to distinct pathophysiological mechanisms and treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: